Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04679675 · ClinicalTrials.gov registry record · NA
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 32,771
- Enrollment target
NCT04679675 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 32,771 participants.
The verdict
NCT04679675, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 32,771 participants
- Enrollment target
Study Summary
The Self-Testing options in the Era of Primary HPV screening for cervical cancer (STEP) trial will evaluate effectiveness of home-based HPV kits for improving cervical cancer screening uptake and its cost-effectiveness. The investigators will compare cervical cancer screening uptake within six months among women randomized to different outreach approaches based on prior screening behavior: A) Adherent and coming due: direct mail HPV kit vs. opt-in HPV kit vs. education; B) Overdue: direct mail HPV kit vs. education; C) Unknown: opt-in HPV kit vs. education.
Interventions
- OTHER Usual Care
- BEHAVIORAL Education
- BEHAVIORAL Direct Mail
- BEHAVIORAL Opt-in
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32,771 participants |
| Start Date | 2020-11-20 |
| Est. Completion | 2023-07-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04679675
The ClinicalTrials.gov registry entry for NCT04679675 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32,771 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Usual Care is the first listed.
NCT04679675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04679675 about?
NCT04679675 is a clinical study titled "Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial". The Self-Testing options in the Era of Primary HPV screening for cervical cancer (STEP) trial will evaluate effectiveness of home-based HPV kits for improving cervical cancer screening uptake and its cost-effectiveness. The investigators will compare cervical cancer screening uptake within six month...
What is the current status of trial NCT04679675?
This trial is currently completed. It is a NA study. The enrollment target is 32,771 participants. The study started on 2020-11-20. Estimated completion is 2023-07-29.
What interventions are being tested in trial NCT04679675?
The interventions under investigation include: Usual Care (OTHER), Education (BEHAVIORAL), Direct Mail (BEHAVIORAL), Opt-in (BEHAVIORAL).
Who is sponsoring clinical trial NCT04679675?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.